Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma. (Q54386219)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma. |
scientific article |
Statements
Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma. (English)
Otto C Boerman
1 reference
Constantijn H J Muselaers
Alexander B Stillebroer
Ingrid M E Desar
Marye J Boers-Sonderen
Carla M L van Herpen
Mirjam C A de Weijert
Johan F Langenhuijsen
Egbert Oosterwijk
William P J Leenders
Peter F A Mulders
Wim J G Oyen
6 January 2014
55
2
242-247